Back to Search Start Over

The Use of Six Sigma to Assess Two Prostheses for Immediate Breast Reconstruction

Authors :
Giovanni Improta
G. Lanzano
Carlo Ricciardi
Giuseppe A. Ferraro
G. Pieretti
E. Crisci
Adelmo Gubitosi
Tomaz Jarm • Aleksandra Cvetkoska • Samo Mahnič-Kalamiza • Damijan Miklavcic Editors
Tomaz Jarm · Aleksandra Cvetkoska · Samo Mahnič-Kalamiza · DamijanMiklavcic Editors
Ricciardi, Carlo
Gubitosi, Adelmo
Lanzano, Giuseppe
Pieretti, Gorizio
Improta, Giovanni
Crisci, Erminia
Ferraro, Giuseppe
Jarm T., Cvetkoska A., Mahnič-Kalamiza S., Miklavcic D.
IFMBE Proceedings
Ricciardi, C.
Gubitosi, A.
Lanzano, G.
Pieretti, G.
Improta, G.
Crisci, E.
Ferraro, G. A.
Source :
8th European Medical and Biological Engineering Conference ISBN: 9783030646097
Publication Year :
2020
Publisher :
T. Jarm et al. (Eds.) © Springer Nature Switzerland AG 2021, 2020.

Abstract

Breast reconstruction is fundamental and urgent for patients in order to avoid future psychological and physical issues. That’s why immediate breast reconstruction has been requested increasingly in the last years. In this study two prosthesis with different structures and properties were compared according the aesthetic appearance (BREAST-Q© was employed) and five complications (seroma, hematoma, infections, dehiscence and red breast syndrome). The overall population was composed by 56 patients: 24 received a Tutomesh prosthesis and 32 received a Surgimend prosthesis. The DMAIC (define, measure, analyse, improve and control) cycle was implemented as a problem-solving strategy of the Six Sigma to compare the prostheses. While statistically significant difference between the two groups wasn’t found according to the overall BREAST-Q© (p-value = 0.674), the number of complications of the two groups resulted statistically different (p-value of chi-square test less than 0.001). Although it is not possible to understand from this study the reasons of the differences between the complications, this research proved that Surgimend and Tutomesh prostheses can be both implanted safely for immediate breast reconstruction since the higher costs of Surgimend could be neutralized with its lower hospitalization compared to Tutomesh. © 2021, Springer Nature Switzerland AG.

Details

Language :
English
ISBN :
978-3-030-64609-7
ISBNs :
9783030646097
Database :
OpenAIRE
Journal :
8th European Medical and Biological Engineering Conference ISBN: 9783030646097
Accession number :
edsair.doi.dedup.....fc7464b7080e4448720532d04dd59dfa